From the San Francisco Business Times. 23andMe co-founder Anne Wojcicki is back in control of the genetic-testing company. A nonprofit led by Wojcicki — who launched the consumer DNA-test ...

A bankruptcy court this week approved the $305 million sale of genetics testing firm 23andMe to a nonprofit organization led by the company's former CEO Anne Wojcicki, the company announced. The ...

A bankruptcy judge approved the sale of 23andMe's assets and business operations to a nonprofit led by 23andMe’s co-founder and former chief executive, Anne Wojcicki.

That means Wojcicki’s nonprofit TTAM Research Institute will purchase “substantially all” of San Francisco-based 23andMe’s assets for $305 million. The transaction — which arrives more than three ...

NEW YORK (AP) — Anne Wojcicki’s bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. Related Articles.

Anne Wojcicki’s nonprofit gets court approval to buy 23andMe for $305 million Under the deal, TTAM will acquire 23andMe’s signature “Personal Genome Service” provided through the company ...

A U.S. bankruptcy judge has cleared 23andMe’s $305 million sale to TTAM Research, a nonprofit led by co-founder Anne Wojcicki, rejecting California’s attempt to delay the deal over privacy concerns.

NEW YORK (AP) — Anne Wojcicki's bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight.

Anne Wojcicki on genetic privacy, data security, her bid for 23andMe Why California wants to stop 23andMe's sale to former ...

Anne Wojcicki's bid to buy 23andMe, the genetic testing company she cofounded nearly 20 years ago, has received the court greenlight. Posted 2025-07-01T14:47:30+00:00 - Updated 2025-07-03T22:09:50 ...

Anne Wojcicki's nonprofit, TTAM Research Institute, has received court approval to acquire 23andMe, the genetic testing company she co-founded.

Anne Wojcicki stepped down as 23andMe's CEO as the company filed for bankruptcy protection. She cofounded the genetic testing company after a career on Wall Street. Here's a closer look at her ...